PolymarketVerifica disponibilitàSenza KYC2% di commissioneDati di risoluzione verificatiBen calibratoProbabilità implicita attuale
No 94.1%
Qualità del mercato
≤49 / 100
Bassa qualitàVolume 24h
—
Liquidità
32,9K €
Alta liquiditàBid / Ask
5.0% / 6.0%
Spread
1.0 pt
Spread strettoCommenti
7
Dati di mercato
Aggiornato 4 minuti fa
4 mag 26, 14:41 UTC1 gen 27, 04:59 UTC
Trend
Mercati Correlati
Domande correlate per il contesto, non un confronto tra contratti equivalenti.
Will a Hantavirus Vaccine be created in 2026? [Polymarket]
Manifold MarketsHantavirus pandemic in 2026?
PolymarketWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
KalshiHantavirus pandemic in 2026? [Polymarket]
Manifold MarketsWhat will happen related to the Hantavirus in 2026?
Manifold MarketsWill CDC cut the childhood vaccine schedule below 11 diseases in 2026?
KalshiRegole
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET.
- Otherwise, this market will resolve to "No".
- The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), however a consensus of credible reporting may also be used.
Mercati aperti
Health & MedicinePOLYMARKETHantavirus pandemic in 2026?
- No97%
- Yes3%
- Volume totale
- 15,6 Mln €
- Volume 24h
- 11,6K €
POLYMARKETNew pandemic in 2026?
- No-1.0pt93.1%
- Yes+1.0pt6.9%
- Volume totale
- 921K €
- Volume 24h
- 4,7K €
POLYMARKETMeasles cases in U.S. in 2026?
- ↑3.5k100%
- ↑500+0.1pt100%
- ↑1k+0.1pt100%
+9 altri esiti
- Volume totale
KALSHIMedtronic cardiovascular growth in Q2
- Above 8%92%
- Above 9%81%
- Above 11%45%
+6 altri esiti
- Volume totale
- 2,6K €
- Volume 24h
- 1,4K €
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 400097%
- Above 6000-1.0pt60%
+2 altri esiti
- Volume totale
- 869,1K €
- Volume 24h
- 1,3K €
KALSHIPandemic in 2026?
- No95%
- Yes5%
- Volume totale
- 612,8K €
- Volume 24h
- 1,1K €
- When will Beam Therapeutics submit a BLA for Risto-cel?
- Cyclosporiasis cases reported in the US in 2026?
- Measles cases in U.S. by September 30?
- What will RFK say during RNC Midterm Convention?
- Will the FDA approve retatrutide?
- What will the average number of measles cases be during Trump's term?
- When will the FDA approve Intellia Therapeutics' lonvo-z?
- Will WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- How many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?
- Will the FDA approve cytisinicline for smoking cessation?
Domande frequenti
- Quali sono le probabilità attuali per Hantavirus vaccine in 2026??
- Polymarket quota No al 94% al 10 settembre 2026.
- Quando si risolve Hantavirus vaccine in 2026??
- Hantavirus vaccine in 2026? dovrebbe risolversi il 1 gennaio 2027.
- Come viene liquidato Hantavirus vaccine in 2026??
- Polymarket liquida questo mercato come segue: This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET.